Business
First distribution agreements signed for UltraDEX
First distribution agreements signed for UltraDEX.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n \nRNS Number : 9484W Venture Life Group PLC 03 May 2016 \n\nVenture Life Group PLC\n \n(\"Venture Life\" or the \"Group\" or the \"Company\")\n \nFirst distribution agreements signed for UltraDEX range\n \nBracknell, UK - 3 May 2016: Venture Life Group PLC (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it has signed its first new international distribution agreements for the UltraDEX range of fresh breath products since acquiring the range with the Periproducts Limited acquisition which completed on 4 March 2016 (the \"Acquisition\"). \n \nThe Company has signed exclusive five year distribution agreements with Laboratorios Serra Pamies, S.A (\"Serra Pamies\") in Spain and Shanghai Rifto Medical Co., Ltd (\"Shanghai Rifto\") in China.\n \nSerra Pamies was founded in 1885 and is part of the SP Group. Serra Pamies's self-care division promotes its products to pharmacies and specialists, and UltraDEX will be an important product range for them. The experience of Serra Pamies within the Spanish oral healthcare sector has been an important factor in Venture Life's decision to enter into an exclusive distribution agreement with Serra Pamies for the whole of the Spanish market.\n \nShanghai Rifto is a specialist dental sales company selling directly into the dental channel in China and this UltraDEX distribution agreement gives Shanghai Rifto exclusivity in the professional dental sector in this market. In the OTC oral healthcare market in China, brands are typically marketed initially through the dental channel to gain professional endorsement and recommendation to patients. In due course, and as the brand becomes established, Venture Life intends to appoint an appropriate partner as the distributor for UltraDEX in the OTC pharmacy channel.\n \nThe UltraDEX products are already approved for distribution in the EU but the timing of the launch of UltraDEX in China is subject to local registration of the products with the Chinese Food and Drug Administration.\n \nThese agreements reflect the strong interest being seen by Venture Life in the UltraDEX range across Europe and beyond by potential distribution partners since the Acquisition. The combination ...